As it's Christmas,some lively ditties.......
Tuesday, 13 December 2011
Tuesday, 6 December 2011
UK-PCaSO Prostate Cancer Network (Charity)
I thought I'd highlighted this charity before but maybe not.
PCaSO Issue 37 - November 2011 Newsletter (pdf)
I've also added a link to the PCaSO charity website via the main section found within April 2009! and under GENERAL,UROLOGY and CHARITY WEBSITES and also the last repeat found in November under 'Useful Websites'.
| Welcome to PCaSO |
| PCaSO Prostate Cancer Network is a patient-led Support organisation with Branches covering Dorset, Hampshire and Sussex, whose aims are to improve the diagnosis, treatment, care and support to those affected by prostate cancer. The services it offers are free for men, their families and anyone affected by prostate cancer. PCaSO holds meetings in various centres in the South of England from Bournemouth to Eastbourne. It produces newsletters, has free Information Books and a comprehensive Library. The objectives of PCaSO are:
The link below opens their Newsletter for November 2011 which includes The Mediwatch PSA Bioscan System (PSAwatch) and it's use along with event news and other informative articles.
|
I've also added a link to the PCaSO charity website via the main section found within April 2009! and under GENERAL,UROLOGY and CHARITY WEBSITES and also the last repeat found in November under 'Useful Websites'.
Mediwatch-Newsletter Winter 2011
UK - PSAwatch
• Working closely with Mediwatch’s distributor in France, AVF
Biomédical, Mediwatch has launched the PSAwatch system at the
French annual urology congress in Paris. A clinical trial is ongoing.
• Mediwatch has begun direct marketing of PSAwatch into Germany,
Korea, Hong Kong, Europe, Mexico & China.
• In Turkey Mediwatch will be providing tests for a major government
trial as soon as their funding is available.
• Mediwatch is investigating a potential new PSAwatch trial in Italy,
working with its distributor EBNeuro.
• In the UK, the Graham Fulford Charitable Trust (GFCT) has been using the PSAwatch system in conjunction with laboratory tests at events and clinics across the country in 2011. Over the past few years, the GFCT has raised over £275,000 and conducted over 20,000 free prostate cancer tests across the UK, leading to the early diagnosis of nearly 500 men to date. During this quarter the GFCT has been transitioning from the traditional method of shipping blood samples to a laboratory for testing to using PSAwatch as their standard testing method. This model is being rolled-out nationwide through local prostate charity groups and supported by the GFCT.
• Mediwatch met with two multinational pharmaceutical companies
in Mexico to discuss new trials in 2012 using the PSAwatch system,
following trials in 2010 & 2011.
• A large clinical trial is scheduled to begin at the Royal Hospital in
Melbourne in Australia in early 2012.
• In the UAE Mediwatch is investigating the use of PSAwatch in a
national PSA screening program - Mediwatch’s regional manager is
visiting 10 hospitals in 4 of the 7 Emirates to set up trials for 2012.
UK - Sales
• Mediwatch is introducing a new range of equipment for GI &
Neurology diagnostics (including EMG, EEG, and GI & pH studies),
working in conjunction with EBNeuro. The Mediwatch UK sales
representatives have been trained on these products in
November - December 2011.
• Mediwatch attended 5 exhibitions in the UK in 2011, including the
British Urology Association Society annual meeting in Liverpool.
• This year Mediwatch held two National Sales Meetings to review
operations in the UK, bring new representatives into the direct sales
team and introduce additional products to their portfolio, with very
positive results.
UK - R&D
• The UK product development team has been working on several major projects,including a new advanced ultrasound scanner for bladder volume measurements.
• The hardware and software for Mediwatch’s next-generation urodynamics & anorectal manometry system is being worked on in combination by both the UK and USA product development teams.
Asia & Middle East
• Mediwatch enjoyed a year on year sales increase of 50% across the region, largely due to significant sales growth in Japan, Australia, Korea and Malaysia.
• Dr Philip Stimpson & Anders Pedersen travelled to China to meet
with potential distributors and manufacturers in an effort to expand
Mediwatch’s product range. Training has started in mainland China
where Mediwatch has appointed Newaytec in Beijing to represent
Mediwatch’s complete range of products, which are presently going
through SFDA approvals. In anticipation of approvals they attended
the China Medical Equipment Fair exhibition in Shenzhen, the Chinese Urological Association Annual Meeting in Nanjing (showing all Mediwatch’s products on the Newaytec stand), and held a training workshop in Hong Kong where they have succeeded in appointing S&V Samford as our new distributor.
• Mediwatch joined its Japanese distributor, MC Medical to exhibit at the World Endourology Congress in Kyoto.
• Device Technologies, the Mediwatch distributor in Australia & New Zealand, is having a great year. They have managed to secure Clinic Sensic orders in New Zealand and won their first order for a Colorectal System from St Vincent’s Hospital in Australia.
• Mediwatch will be exhibiting at the Arab Health meeting in Dubai in
January 2012.
Europe
• France - AVF Biomédical had a strong year end sales performance across the range of products, in total increasing by 19% from 2010.
• Germany - Promedia year on year sales increased by 10%.
• Russia - Strong sales throughout 2011 by Infomed were double those from 2010, particularly for the urodynamics range.
• Mediwatch is negotiating with a large European company to buy and license new technology for gastro-intestinal diagnostic applications.
Global
• The Allergan trial using Mediwatch’s Urodyn+ flowmeters was
scheduled to end in 2011 but has been extended and is still
ongoing, with Mediwatch’s equipment being used in hospitals
around the world.
USA - Sales
• In the USA Mediwatch is now enrolled in the government bid
contracting system, allowing Mediwatch to more easily sell to the
large Veterans’ Association and military hospital network. Mediwatch
is also now contracted with several private sector group purchasing
organizations (GPOs), which gives Mediwatch the ability to market and sell to potential customers that are contracted with those GPOs.
• This year Mediwatch attended a total of 20 conferences in the USA.At the American Urology Association (AUA) national congress in Washington DC Mediwatch showed off its complete equipment range on a new exhibition stand. In May 2012 Mediwatch will be attending the AUA in Atlanta Georgia.
• Mediwatch is working with two large distribution companies to use their national sales teams to reach additional markets.
• Mobilewatch continues to expand under the leadership of Adam Silbersweig and Diane Durell, with new customers in Washington state and Florida. A dedicated web portal for Mobilewatch in the USA is being set up to market to customers.
USA - R&D
• Mediwatch’s product development team has several new products
in the pipeline, and is working on EMR (electronic medical records)
connectivity. All of Mediwatch’s past customers are potential targets
for this EMR connectivity upgrade. This ongoing development improves Mediwatch’s present EMR connectivity with additional features and smoother setup. EMR is an enhancement that the marketplace is demanding more and more frequently.
Latin America
• This quarter Mediwatch held discussions with potential new
distributors in Brazil, Peru, Costa Rica, Ecuador, Columbia and
Argentina (in October Mediwatch exhibited at the Argentinian national urology meeting in Buenos Aires).
• Mediwatch is working closely with its Mexican distributor, Endomedica, to extend its share of the PSA testing market. Mediwatch will be training end-users and Endomedica sales staff in Mexico City in December at a hospital that recently purchased two large capital systems.
• Mediwatch’s goal for 2012 is to have strong representation in North, Central and South America, in particular in the above countries.
Canada
• Mediwatch has been setting up a distribution network in Canada,
with representation in British Columbia, Ontario & the Maritimes,
and a regional sales manager based in the USA. Mediwatch are in
negotiations at present for representation in Quebec and other regions to complete sales coverage across the country.
Staff changes in the USA
• Brian Hersh BA, joined as the VP of US operations in August 2011. He has a diverse background in Corporate Finance, Sales & Marketing, Operations and Business Development. Most recently he has used his diverse experience and skill sets to help many companies in the role of Business Consultant and Growth Strategist. His experience in medical laboratory management, pharmaceutical, diagnostic testing, and internet based marketing all bring key skills to Mediwatch.
• Mike Bradley MBA, the newly appointed West Coast Sales Manager,
joins Casey Rosa and Jeff Dannenberg to fill a key gap in Mediwatch’s sales structure. He is working to bring Mediwatch comprehensive coverage over the Western region, in particular strengthening the Californian sales team.
• Adam Silbersweig joined the Mobilewatch management team and brings telesales and diagnostic testing experience to the Mobile team. The Florida office is experimenting with an external sales team,travelling out to visit clients and market the Mobilewatch service.
• Jorge Bracho M.D. has joined the Mediwatch clinical team. He combines clinical expertise for customer support with Latin American sales management.
• Graham Taylor-Jones MEng joins the product development team with a specialty in hardware. Alicia Gardner BA joins the product development team with an emphasis on software. Eddie Johnson has transferred from service to product development, he is focusing on the EMR connectivity project.
Staff changes in the UK
• Colm Croskery FCA B,Comm MBA has transferred to group CFO for
Mediwatch Plc. Colm has been with Mediwatch since July 2007,
initially joining as Operations Manager, becoming a director in
January 2008.
• Peter Griffiths MBA, is the new Mediwatch General Manager of
Operations in the UK. He has an impressive operations background
in high tech regulated sectors, including the media, electronics,
polymer science, Tier 1 aerospace manufacture and more recently
bio-compatible materials for medical device manufacturers. Peter
is working closely with the UK management team to improve the
manufacturing and production process along with improving the
timeline for new product development.
• Howard Brobin has been promoted to UK sales manager. He has
21 years of experience of selling urology and neuro-physiology
equipment, in particular urodynamics systems, into the UK market.
• Working closely with Mediwatch’s distributor in France, AVF
Biomédical, Mediwatch has launched the PSAwatch system at the
French annual urology congress in Paris. A clinical trial is ongoing.
• Mediwatch has begun direct marketing of PSAwatch into Germany,
Korea, Hong Kong, Europe, Mexico & China.
• In Turkey Mediwatch will be providing tests for a major government
trial as soon as their funding is available.
• Mediwatch is investigating a potential new PSAwatch trial in Italy,
working with its distributor EBNeuro.
• In the UK, the Graham Fulford Charitable Trust (GFCT) has been using the PSAwatch system in conjunction with laboratory tests at events and clinics across the country in 2011. Over the past few years, the GFCT has raised over £275,000 and conducted over 20,000 free prostate cancer tests across the UK, leading to the early diagnosis of nearly 500 men to date. During this quarter the GFCT has been transitioning from the traditional method of shipping blood samples to a laboratory for testing to using PSAwatch as their standard testing method. This model is being rolled-out nationwide through local prostate charity groups and supported by the GFCT.
• Mediwatch met with two multinational pharmaceutical companies
in Mexico to discuss new trials in 2012 using the PSAwatch system,
following trials in 2010 & 2011.
• A large clinical trial is scheduled to begin at the Royal Hospital in
Melbourne in Australia in early 2012.
• In the UAE Mediwatch is investigating the use of PSAwatch in a
national PSA screening program - Mediwatch’s regional manager is
visiting 10 hospitals in 4 of the 7 Emirates to set up trials for 2012.
UK - Sales
• Mediwatch is introducing a new range of equipment for GI &
Neurology diagnostics (including EMG, EEG, and GI & pH studies),
working in conjunction with EBNeuro. The Mediwatch UK sales
representatives have been trained on these products in
November - December 2011.
• Mediwatch attended 5 exhibitions in the UK in 2011, including the
British Urology Association Society annual meeting in Liverpool.
• This year Mediwatch held two National Sales Meetings to review
operations in the UK, bring new representatives into the direct sales
team and introduce additional products to their portfolio, with very
positive results.
UK - R&D
• The UK product development team has been working on several major projects,including a new advanced ultrasound scanner for bladder volume measurements.
• The hardware and software for Mediwatch’s next-generation urodynamics & anorectal manometry system is being worked on in combination by both the UK and USA product development teams.
Asia & Middle East
• Mediwatch enjoyed a year on year sales increase of 50% across the region, largely due to significant sales growth in Japan, Australia, Korea and Malaysia.
• Dr Philip Stimpson & Anders Pedersen travelled to China to meet
with potential distributors and manufacturers in an effort to expand
Mediwatch’s product range. Training has started in mainland China
where Mediwatch has appointed Newaytec in Beijing to represent
Mediwatch’s complete range of products, which are presently going
through SFDA approvals. In anticipation of approvals they attended
the China Medical Equipment Fair exhibition in Shenzhen, the Chinese Urological Association Annual Meeting in Nanjing (showing all Mediwatch’s products on the Newaytec stand), and held a training workshop in Hong Kong where they have succeeded in appointing S&V Samford as our new distributor.
• Mediwatch joined its Japanese distributor, MC Medical to exhibit at the World Endourology Congress in Kyoto.
• Device Technologies, the Mediwatch distributor in Australia & New Zealand, is having a great year. They have managed to secure Clinic Sensic orders in New Zealand and won their first order for a Colorectal System from St Vincent’s Hospital in Australia.
• Mediwatch will be exhibiting at the Arab Health meeting in Dubai in
January 2012.
Europe
• France - AVF Biomédical had a strong year end sales performance across the range of products, in total increasing by 19% from 2010.
• Germany - Promedia year on year sales increased by 10%.
• Russia - Strong sales throughout 2011 by Infomed were double those from 2010, particularly for the urodynamics range.
• Mediwatch is negotiating with a large European company to buy and license new technology for gastro-intestinal diagnostic applications.
Global
• The Allergan trial using Mediwatch’s Urodyn+ flowmeters was
scheduled to end in 2011 but has been extended and is still
ongoing, with Mediwatch’s equipment being used in hospitals
around the world.
USA - Sales
• In the USA Mediwatch is now enrolled in the government bid
contracting system, allowing Mediwatch to more easily sell to the
large Veterans’ Association and military hospital network. Mediwatch
is also now contracted with several private sector group purchasing
organizations (GPOs), which gives Mediwatch the ability to market and sell to potential customers that are contracted with those GPOs.
• This year Mediwatch attended a total of 20 conferences in the USA.At the American Urology Association (AUA) national congress in Washington DC Mediwatch showed off its complete equipment range on a new exhibition stand. In May 2012 Mediwatch will be attending the AUA in Atlanta Georgia.
• Mediwatch is working with two large distribution companies to use their national sales teams to reach additional markets.
• Mobilewatch continues to expand under the leadership of Adam Silbersweig and Diane Durell, with new customers in Washington state and Florida. A dedicated web portal for Mobilewatch in the USA is being set up to market to customers.
USA - R&D
• Mediwatch’s product development team has several new products
in the pipeline, and is working on EMR (electronic medical records)
connectivity. All of Mediwatch’s past customers are potential targets
for this EMR connectivity upgrade. This ongoing development improves Mediwatch’s present EMR connectivity with additional features and smoother setup. EMR is an enhancement that the marketplace is demanding more and more frequently.
Latin America
• This quarter Mediwatch held discussions with potential new
distributors in Brazil, Peru, Costa Rica, Ecuador, Columbia and
Argentina (in October Mediwatch exhibited at the Argentinian national urology meeting in Buenos Aires).
• Mediwatch is working closely with its Mexican distributor, Endomedica, to extend its share of the PSA testing market. Mediwatch will be training end-users and Endomedica sales staff in Mexico City in December at a hospital that recently purchased two large capital systems.
• Mediwatch’s goal for 2012 is to have strong representation in North, Central and South America, in particular in the above countries.
Canada
• Mediwatch has been setting up a distribution network in Canada,
with representation in British Columbia, Ontario & the Maritimes,
and a regional sales manager based in the USA. Mediwatch are in
negotiations at present for representation in Quebec and other regions to complete sales coverage across the country.
Staff changes in the USA
• Brian Hersh BA, joined as the VP of US operations in August 2011. He has a diverse background in Corporate Finance, Sales & Marketing, Operations and Business Development. Most recently he has used his diverse experience and skill sets to help many companies in the role of Business Consultant and Growth Strategist. His experience in medical laboratory management, pharmaceutical, diagnostic testing, and internet based marketing all bring key skills to Mediwatch.
• Mike Bradley MBA, the newly appointed West Coast Sales Manager,
joins Casey Rosa and Jeff Dannenberg to fill a key gap in Mediwatch’s sales structure. He is working to bring Mediwatch comprehensive coverage over the Western region, in particular strengthening the Californian sales team.
• Adam Silbersweig joined the Mobilewatch management team and brings telesales and diagnostic testing experience to the Mobile team. The Florida office is experimenting with an external sales team,travelling out to visit clients and market the Mobilewatch service.
• Jorge Bracho M.D. has joined the Mediwatch clinical team. He combines clinical expertise for customer support with Latin American sales management.
• Graham Taylor-Jones MEng joins the product development team with a specialty in hardware. Alicia Gardner BA joins the product development team with an emphasis on software. Eddie Johnson has transferred from service to product development, he is focusing on the EMR connectivity project.
Staff changes in the UK
• Colm Croskery FCA B,Comm MBA has transferred to group CFO for
Mediwatch Plc. Colm has been with Mediwatch since July 2007,
initially joining as Operations Manager, becoming a director in
January 2008.
• Peter Griffiths MBA, is the new Mediwatch General Manager of
Operations in the UK. He has an impressive operations background
in high tech regulated sectors, including the media, electronics,
polymer science, Tier 1 aerospace manufacture and more recently
bio-compatible materials for medical device manufacturers. Peter
is working closely with the UK management team to improve the
manufacturing and production process along with improving the
timeline for new product development.
• Howard Brobin has been promoted to UK sales manager. He has
21 years of experience of selling urology and neuro-physiology
equipment, in particular urodynamics systems, into the UK market.
Friday, 2 December 2011
LATEST NEWS AND FUTURE EVENTS
Latest News/Website Updates
Repaired the broken link to 'PROSTaid' and added PCaSO to the charity site page.
Renal And Urology News-December 2011 Edition
Urology Times-November 2011 EditionMediwatch Positions/Jobs
Mediwatch Training Courses
Three new workshops announced for 2012:
Urodynamics Workshop WPB Date 11,12 Feb 2012 Deadline 27 Jan
ARM Workshop Boston Date 13th Apr 2012 Deadline 23rd Mar
Urodynamics Workshop WPB Date 13,14 Oct 2012 Deadline 28 Sep
Future Events Events where Mediwatch are attending/exhibiting will be marked as so or updated,hopefully before the event is finished.More Events to add later
STUFF THAT MAYBE DID BUT NOW DOESN'T FIT IN WITH THE TITLE...
Staffordshire University Honorary Doctors 2011-Philip Stimpson-July 2011
Directors' Shareholdings-Issued 28th July
Interim Results for the six months to 30 April 2011-This copy 28th July (RNS-26th July)
Mediwatch-Annual Report-Issued 24th March 2011
Mediwatch-Final Results for year ended 31 October 2010-Issued 27th January 2011
Mediwatch USA Inc. Awarded US General Service Administration Federal Supply Schedule Contract 14th December
OEM Partnership with ACON Laboratories 1st November
Website Update (Aug)-Mobile Watch
Interim Results
Mediwatch Newsletter-July 2010 Edition
OEM Partnership with Thought Technology Ltd Mediwatch-14th June
Distribution Agreement with GE Healthcare Mediwatch-8th June
Tuesday, 22 November 2011
UK-Prostate Awareness Road shows
This is from the Graham Fulford Charitable Trust which has been mentioned before on this blog and I hope they along with Mediwatch are okay about me highlighting this below along with a link at BOP for the full manual
Prostate Awareness Road shows
Including Point Of Care Testing
Event Guidance Manual
First Prepared: August 2011
Guidance Manual
Contents
• Introduction
• Background
• How To Get Started
• How To Run Ongoing Road Shows
• Post Road Show Activities
• Conclusion
• Appendices
This manual has been developed as a guide to groups putting on
Prostate Health Awareness road shows including PSA tests using the
Mediwatch PSA watch Bioscan which is designed to give an “indicative” PSA score within ten minutes of the sample being processed. By definition this manual is embryonic and user’s feedback will be much appreciated.
Background
The Graham Fulford Charitable Trust was formed by Graham Fulford
late 2004 having had a very dear friend and a close relative diagnosed with prostate cancer. Sadly both lost their fight against this insidious disease having, like many, been diagnosed too late.
Over the last 7 years the Trust has, working closely with David Baxter
Smith M.A,M.Sc.,B.A.O.,F.R.C.S. Consultant Urological Surgeon and the Kidderminster Prostate Cancer Support Group carried out approaching 18,000 PSA tests all over the country and have found in excess of 422 prostate cancers at the time of writing. During this period the trust has been liaising with Mediwatch to help them refine the accuracy of the testing strips used by their PSA watch point of care Bioscan machine.
The great advantage of using these is not only the speed of response of getting the result (10 minutes as against up to 14 days) but also the flexibility it gives in enabling regular events to be held in local
communities without the need for large halls and very expensive lab machines etc.
This manual is designed to help a launch of using these machines more widely. In effect any “group” having Bioscans and a pool of helpers (particularly people trained in the operation of the Bioscan) can offer a “stand alone” awareness facility. Having used the term “stand alone” it is essential to understand all such groups will have the full support of TGFCT (with the experience gained in holding in excess of 100 events all over the country) David Baxter Smith and the team at Mediwatch.
Please feel free to contact them at any time.
Thursday, 10 November 2011
Wednesday, 2 November 2011
LATEST NEWS AND FUTURE EVENTS
Latest News/Website Updates
Renal And Urology News-October 2011 Edition
Urology Times-October 2011 EditionMediwatch Positions/Jobs
Sales Representative - Medical Devices
Location: London , South East
Salary: OTE £36K
Date posted: 02/11/2011 20:01
Company: Mediwatch UK Ltd
Contact: Julie Green Ref: Salestarget Job ID: 51998754
Sales Representative – Healthcare – Medical Devices
About the Job
Sales Representative – Urology – Cancer – Ultrasound - GI - Neuro Location, London, Home Counties, up to Leicester. OTE £36,000 + Car and Mileage allowance, Laptop, Mobile Phone.
Mediwatch UK Ltd have a fantastic opportunity for an enthusiastic experienced Sales Representative to join the team and further expand our sales revenues. You will be based around north London, and spend most of your days in the field finding and closing sales on Urology/Urodynamics/ Ultrasound/GI/Neuro, Cancer testing point of care devices and accompanying consumables.
Selling directly to Secondary care, as well as Charities Private Hospitals, and some Primary care providers, you will be self motivated and have the will to win the business. Full and continuous training on our product range will be provided.
Skills and Experience: Educated to Degree level, or equivalent, Medical Sales or Engineers with Product Support experience.
Hungry, commercially driven, with a will to succeed. Excellent technical ability, including Microsoft based products. Excellent communication skills, A willingness to go beyond the normal. Full Driving License
Current Eligibility to Live and Work in the UK.
Mediwatch Training Courses
Mediwatch USA-Basic Urodynamics Clinicians’ Workshop USA 12th-13th November
Future Events Events where Mediwatch are attending/exhibiting will be marked as so or updated,hopefully before the event is finished.More Events to add later
Walt Disney World Swan Hotel November 3-5, 2011
Mediwatch USA Inc. are exhibiting T19
2011 Annual Meeting Exhibitor List and
Floorplan
Mediwatch USA Inc. are exhibiting T19
STUFF THAT MAYBE DID BUT NOW DOESN'T FIT IN WITH THE TITLE...
Staffordshire University Honorary Doctors 2011-Philip Stimpson-July 2011
Directors' Shareholdings-Issued 28th July
Interim Results for the six months to 30 April 2011-This copy 28th July (RNS-26th July)
Mediwatch-Annual Report-Issued 24th March 2011
Mediwatch-Final Results for year ended 31 October 2010-Issued 27th January 2011
Mediwatch USA Inc. Awarded US General Service Administration Federal Supply Schedule Contract 14th December
OEM Partnership with ACON Laboratories 1st November
Website Update (Aug)-Mobile Watch
Interim Results
Mediwatch Newsletter-July 2010 Edition
OEM Partnership with Thought Technology Ltd Mediwatch-14th June
Distribution Agreement with GE Healthcare Mediwatch-8th June
Subscribe to:
Posts (Atom)